masoprocol and Diabetes Mellitus, Type 2

masoprocol has been researched along with Diabetes Mellitus, Type 2 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (60.00)18.2507
2000's0 (0.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lunder, M; Roškar, I; Štrukelj, B1
Dain, A; Das, UN; Diaz-Gerevini, GT; Eynard, AR; Repossi, G; Vanamala, J1
Bensaoula, T; Eichberg, J; Ottlecz, A; Peterson, RG1
Carlson, TJ; Cheung, J; Chuang, T; Hector, RF; King, SR; Luo, J; Meszaros, K; Quan, J; Reaven, GM; Reed, MJ; Sullivan, C; Tsai, J1
Brignetti, D; Claypool, MD; Entes, LJ; Khandwala, A; Luo, J; Meszaros, K; Pinkett, JG; Reaven, GM; Reed, MJ1

Other Studies

5 other study(ies) available for masoprocol and Diabetes Mellitus, Type 2

ArticleYear
Screening of Phenolic Compounds Reveals Inhibitory Activity of Nordihydroguaiaretic Acid Against Three Enzymes Involved in the Regulation of Blood Glucose Level.
    Plant foods for human nutrition (Dordrecht, Netherlands), 2016, Volume: 71, Issue:1

    Topics: alpha-Amylases; alpha-Glucosidases; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Larrea; Masoprocol; Phenols; Postprandial Period

2016
Long chain polyunsaturated fatty acids (LCPUFAs) and nordihydroguaiaretic acid (NDGA) modulate metabolic and inflammatory markers in a spontaneous type 2 diabetes mellitus model (Stillman Salgado rats).
    Lipids in health and disease, 2016, Nov-25, Volume: 15, Issue:1

    Topics: Animals; Arachidonic Acid; Biomarkers; C-Reactive Protein; Diabetes Mellitus, Type 2; Dietary Supplements; Disease Models, Animal; Fatty Acids, Omega-3; gamma-Glutamyltransferase; Glycated Hemoglobin; Inflammation; Interleukin-6; Male; Masoprocol; Rats; Rats, Wistar; Triglycerides

2016
Angiotensin-converting enzyme activity in retinas of streptozotocin-induced and Zucker diabetic rats. The effect of angiotensin II on Na+,K(+)-ATPase activity.
    Investigative ophthalmology & visual science, 1996, Volume: 37, Issue:11

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Biphenyl Compounds; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Imidazoles; Isoenzymes; Lipoxygenase Inhibitors; Losartan; Male; Masoprocol; Peptidyl-Dipeptidase A; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Rats, Zucker; Retina; Sodium-Potassium-Exchanging ATPase; Tetrazoles; Vasoconstrictor Agents

1996
Masoprocol (nordihydroguaiaretic acid): a new antihyperglycemic agent isolated from the creosote bush (Larrea tridentata).
    European journal of pharmacology, 1998, Apr-03, Volume: 346, Issue:1

    Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Disease Models, Animal; Hypoglycemic Agents; Insulin; Male; Masoprocol; Mice; Mice, Inbred C57BL; Plants, Medicinal

1998
Effect of masoprocol on carbohydrate and lipid metabolism in a rat model of Type II diabetes.
    Diabetologia, 1999, Volume: 42, Issue:1

    Topics: Adipocytes; Animals; Antioxidants; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dietary Fats; Fatty Acids, Nonesterified; Feeding Behavior; Hypoglycemic Agents; Insulin; Male; Masoprocol; Metformin; Rats; Rats, Sprague-Dawley; Triglycerides

1999